PM Modi to embark on three city visit tomorrow to review COVID-19 vaccine development

Prime Minister  Narendra Modi will embark on a three city visit tomorrow to personally review the COVID-19 vaccine development and  manufacturing process. The Prime Minister's Office in a tweet said that Mr  Modi will visit the Zydus Biotech Park in Ahmedabad, Bharat Biotech in Hyderabad and  Serum Institute of India in Pune.

It said, as India enters a decisive phase of the fight against COVID-19, Prime Minister Narendra Modi's  visit to these facilities and  discussions with the scientists will help him get a first hand perspective of the preparations, challenges and  roadmap in India’s endeavour to vaccinate its citizens.

Prime Minister Narendra Modi will first visit the Zydus Cadila Pharmaceutical’s vaccine development facility at Zydus Biotech Park near Ahmedabad tomorrow morning to personally review the Covid vaccine development process.

AIR Ahmedabad correspondent reports that the Zydus plant which is working on ZyCoV-D, a Covid19 vaccine candidate is located in Changodar area of Ahmedabad Gujarat. A helipad facility has been set up close to the plant for the Prime Minister’s visit.

After his visit to Ahmedabad, the Prime Minister is expected to  fly to Pune, to visit the Serum Institute to review the production of corona vaccine COVISHIELD. Our Pune Correspondent reports that Mr. Modi will discuss with the concerned officials about the overall supply and distribution system after the successful testing of this vaccine.

According to the schedule, after arrival at Lohegaon airport, the Prime Minister will be flown directly to Serum Institute by a special helicopter and will be at the institute for about an hour.

After the visit to the institute, the Prime Minister will leave for Hyderabad from Lohegaon Airport.

Our Hyderabad Correspondent says, the Prime Minister is scheduled to arrive at Hakimpet Air Force Station, Hyderabad tomorrow in the afternoon.

Mr.Modi is expected to reach the vaccine manufacturing facility of Bharat Biotech International Limited (BBIL) and review the Covid-19 Vaccine manufacturing process. The BBIL is engaged in the manufacturing of  COVID-19 vaccine called Covaxin in collaboration with the Indian Council of Medical Research (ICMR).

Popular posts from this blog

30 security personnel killed in a car bomb blast in Ghazni province in Afghanistan

11 per cent GDP growth projected by Economic Survey 2020-21 for next financial year

Pradhan Mantri Fasal Bima Yojana completes 5 years; govt urges farming community to take advantage of scheme